0.00Open0.05Pre Close0 Volume29 Open Interest7.50Strike Price0.00Turnover1839.79%IV11.03%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier-7DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.1305Delta0.2633Gamma136.00Leverage Ratio-5.0507Theta0.0000Rho17.75Eff Leverage0.0001Vega
Voyager Therapeutics Stock Discussion
Voyager Therapeutics Says First Participants Dosed In Single Ascending Dose Trial of VY-TAU01 For Treatment Of Alzheimer's Disease
No comment yet